Pending actions
514
Historical total
616
Resolved / remanded
102
Active. A substantial share of actions remain pending. Of 616 lawsuits ever part of this litigation, 514 remain active.
About this litigation
Insulin Pricing Litigation is a federal multidistrict litigation classified by the Judicial Panel on Multidistrict Litigation as a Sales Practices docket. It was centralized on August 3, 2023 before Brian R. Martinotti, U.S. District Judge, in the D. New Jersey.
As of the August 3, 2026 JPML report, 514 individual lawsuits are pending in this MDL. Cases coordinated in an MDL keep their separate identity — they are managed together only for pretrial proceedings. Learn how MDLs work.
Related Sales Practices MDLs
View categoryDividend Solar Finance, LLC, and Fifth Third Bank Sales and Lending Practices Litigation
42
pending actions
MDL 3128
D. Minnesota
Santa Fe Natural Tobacco Company Marketing and Sales Practices Litigation
17
pending actions
MDL 2695
D. New Mexico
General Motors Air Conditioning Marketing and Sales Practices Litigation
15
pending actions
MDL 2818
E.D. Michigan
Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
13
pending actions
MDL 2700
N.D. Oklahoma